Brivera 25mg Tablet – Adjunctive Therapy for Partial-Onset Seizures in Epilepsy
Brivera 25mg Tablet – Adjunctive Therapy for Partial-Onset Seizures in Epilepsy
Brivera 25mg Tablet – Adjunctive Therapy for Partial-Onset Seizures in Epilepsy
Description
Brivera 25mg Tablet – Reliable Antiepileptic for Seizure Control
Brivera 25mg Tablet contains Brivaracetam, a selective synaptic vesicle protein 2A (SV2A) ligand that modulates neurotransmitter release to reduce seizure activity in the brain. It is indicated as adjunctive treatment for partial-onset seizures with or without secondary generalization in adults and adolescents aged 16 years and older with epilepsy. This prescription medication offers rapid onset and high bioavailability, helping to minimize seizure frequency when added to existing antiepileptic regimens, without significant drug interactions that complicate therapy.
